Try our Advanced Search for more refined results

39 Nexium Bone Density Suits Consolidated By MDL Panel

By Sean McLernon (December 6, 2012, 7:58 PM EST) -- The U.S. Judicial Panel on Multidistrict Litigation on Thursday consolidated 39 suits claiming the AstraZeneca LP heartburn drug Nexium causes bone density loss, shooting down the pharmaceutical company's argument that distinct causation and product identification questions justify keeping the cases separate....

Law360 is on it, so you are, too.

A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.


A Law360 subscription includes features such as

  • Daily newsletters
  • Expert analysis
  • Mobile app
  • Advanced search
  • Judge information
  • Real-time alerts
  • 450K+ searchable archived articles

And more!

Experience Law360 today with a free 7-day trial.

Start Free Trial

Already a subscriber? Click here to login

Attached Documents

Related Sections

Law Firms

Companies

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!